ÂÜÀòÂÒÂ×

Marinna Madrid, PhD, currently serves as the Co-Founder and Chief Product Officer at Cellino since 2017. In addition to this role, Marinna is a Strategic Advisory Board Member at Altius Bioventures, a position held since November 2023. Marinna actively contributes as an Invited Committee Member on the JSRM-ISCT iPSC Committee for the International Society for Cell & Gene Therapy since March 2022, and serves on the Industry Liaison Committee for the Global Alliance for iPSC Therapies (GAiT) since June 2021. Marinna is also a member of the Autologous iPSC-based Cell Therapy Consortium since October 2020. Educational qualifications include a PhD in Applied Physics from Harvard University and a BS in Physics/Biophysics from UCLA, with prior coursework at Riverside City College.